{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:09:50Z","timestamp":1790672990417,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T00:00:00Z","timestamp":1734220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T00:00:00Z","timestamp":1734220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40256-024-00704-x","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T14:33:11Z","timestamp":1734273191000},"page":"349-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review"],"prefix":"10.1007","volume":"25","author":[{"given":"Mary-Tiffany","family":"Oduah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubadewa A.","family":"Fatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naba","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"LeMond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Sama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-7786","authenticated-orcid":false,"given":"Onyedika J.","family":"Ilonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,15]]},"reference":[{"issue":"11","key":"704_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, et al. Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2019;21(11):1338\u201352. https:\/\/doi.org\/10.1002\/ejhf.1492.","journal-title":"Eur J Heart Fail"},{"issue":"38","key":"704_CR2","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","journal-title":"Eur Heart J"},{"issue":"24","key":"704_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological D, Stroke rt PASSG","year":"1995","unstructured":"National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med. 1995;333(24):1581\u20137. https:\/\/doi.org\/10.1056\/NEJM199512143332401.","journal-title":"New Engl J Med."},{"issue":"7","key":"704_CR4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/eurheartj\/ehp458","volume":"31","author":"A Mebazaa","year":"2010","unstructured":"Mebazaa A, Pang PS, Tavares M, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J. 2010;31(7):832\u201341. https:\/\/doi.org\/10.1093\/eurheartj\/ehp458.","journal-title":"Eur Heart J"},{"issue":"9860","key":"704_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (London, England). 2013;381(9860):29\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(12)61855-8.","journal-title":"Lancet (London, England)."},{"issue":"11","key":"704_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34(11):835\u201343. https:\/\/doi.org\/10.1093\/eurheartj\/ehs444.","journal-title":"Eur Heart J"},{"issue":"5","key":"704_CR7","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1002\/ehf2.12842","volume":"7","author":"M Rivas-Lasarte","year":"2020","unstructured":"Rivas-Lasarte M, Maestro A, Fernandez-Martinez J, et al. Prevalence and prognostic impact of subclinical pulmonary congestion at discharge in patients with acute heart failure. ESC Heart Fail. 2020;7(5):2621\u20138. https:\/\/doi.org\/10.1002\/ehf2.12842.","journal-title":"ESC Heart Fail."},{"issue":"18","key":"704_CR8","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","journal-title":"Circulation"},{"issue":"7","key":"704_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jchf.2023.04.010","volume":"11","author":"N Narang","year":"2023","unstructured":"Narang N, Blumer V, Jumean MF, et al. Management of heart failure-related cardiogenic shock: practical guidance for clinicians. JACC Heart Fail. 2023;11(7):845\u201351. https:\/\/doi.org\/10.1016\/j.jchf.2023.04.010.","journal-title":"JACC Heart Fail."},{"issue":"25","key":"704_CR10","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","volume":"69","author":"Y Matsue","year":"2017","unstructured":"Matsue Y, Damman K, Voors AA, et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(25):3042\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.042.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"704_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12742","volume":"13","author":"AM Iqbal","year":"2021","unstructured":"Iqbal AM, Mohammed SK, Zubair N, et al. The impact of door to diuretic time in acute heart failure on hospital length of stay and in-patient mortality. Cureus. 2021;13(1): e12742. https:\/\/doi.org\/10.7759\/cureus.12742.","journal-title":"Cureus."},{"key":"704_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijcard.2018.06.087","volume":"269","author":"MJ Ward","year":"2018","unstructured":"Ward MJ, Collins SP, Liu D, Froehle CM. Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. Int J Cardiol. 2018;269:207\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.087.","journal-title":"Int J Cardiol"},{"key":"704_CR13","unstructured":"Mir J MS, Alan M, Bell T, Malik A. Effect of Door To Diuretic Time In Acute Heart Failure. August 14, 2024. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S107191642031085X?via%3Dihub. Accessed 26 Oct 2024."},{"issue":"5","key":"704_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/JCN.0000000000000932","volume":"37","author":"DJ Dzikowicz","year":"2022","unstructured":"Dzikowicz DJ, Pokhrel Bhattarai S, Ng J, Zemanek AL, Carey MG. Delays in door-to-diuretic time and 1-year mortality among patients with heart failure. J Cardiovasc Nurs. 2022;37(5):410\u20137. https:\/\/doi.org\/10.1097\/JCN.0000000000000932.","journal-title":"J Cardiovasc Nurs"},{"issue":"1","key":"704_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejhf.2708","volume":"25","author":"W Ouwerkerk","year":"2023","unstructured":"Ouwerkerk W, Tromp J, Cleland JGF, et al. Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail. 2023;25(1):43\u201351. https:\/\/doi.org\/10.1002\/ejhf.2708.","journal-title":"Eur J Heart Fail"},{"key":"704_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.amjcard.2021.01.040","volume":"147","author":"Y Horiuchi","year":"2021","unstructured":"Horiuchi Y, Wettersten N, van Veldhuisen DJ, et al. Relation of decongestion and time to diuretics to biomarker changes and outcomes in acute heart failure. Am J Cardiol. 2021;147:70\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2021.01.040.","journal-title":"Am J Cardiol"},{"issue":"4","key":"704_CR17","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/ehf2.13379","volume":"8","author":"T Mikami","year":"2021","unstructured":"Mikami T, Ishii M, Yamamoto N, et al. Association of early administration of furosemide with improved oxygenation in patients with acute heart failure. ESC Heart Fail. 2021;8(4):3354\u20139. https:\/\/doi.org\/10.1002\/ehf2.13379.","journal-title":"ESC Heart Fail."},{"issue":"4","key":"704_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jchf.2017.12.017","volume":"6","author":"JJ Park","year":"2018","unstructured":"Park JJ, Kim SH, Oh IY, et al. The effect of door-to-diuretic time on clinical outcomes in patients with acute heart failure. JACC Heart Fail. 2018;6(4):286\u201394. https:\/\/doi.org\/10.1016\/j.jchf.2017.12.017.","journal-title":"JACC Heart Fail."},{"issue":"7","key":"704_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jacc.2008.05.010","volume":"52","author":"AS Maisel","year":"2008","unstructured":"Maisel AS, Peacock WF, McMullin N, et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008;52(7):534\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.010.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"704_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ahj.2013.05.014","volume":"166","author":"YW Wong","year":"2013","unstructured":"Wong YW, Fonarow GC, Mi X, et al. Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). Am Heart J. 2013;166(2):349\u201356. https:\/\/doi.org\/10.1016\/j.ahj.2013.05.014.","journal-title":"Am Heart J"},{"issue":"2","key":"704_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MEJ.0000000000001006","volume":"30","author":"P Marques","year":"2023","unstructured":"Marques P, Brito MT, Vasques-Novoa F, et al. Door-to-furosemide time and clinical outcomes in acute heart failure. Eur J Emerg Med. 2023;30(2):85\u201390. https:\/\/doi.org\/10.1097\/MEJ.0000000000001006.","journal-title":"Eur J Emerg Med"},{"key":"704_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ahj.2023.12.012","volume":"269","author":"T Sampaio Rodrigues","year":"2024","unstructured":"Sampaio Rodrigues T, Garcia Quarto LJ, Nogueira SC, et al. Door-to-diuretic time and mortality in patients with acute heart failure: a systematic review and meta-analysis. Am Heart J. 2024;269:205\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2023.12.012.","journal-title":"Am Heart J"},{"issue":"25","key":"704_CR23","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.jacc.2017.05.009","volume":"69","author":"JL Januzzi Jr","year":"2017","unstructured":"Januzzi JL Jr, Felker GM. Door-to-furosemide therapy in the ED: new quality metric or just a piece of the puzzle? J Am Coll Cardiol. 2017;69(25):3052\u20134. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.009.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"704_CR24","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Bamadhaj S, Cleland JGF, et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health. 2020;8(3):e411\u201322. https:\/\/doi.org\/10.1016\/S2214-109X(20)30004-8.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"704_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamacardio.2019.5108","volume":"5","author":"G Filippatos","year":"2020","unstructured":"Filippatos G, Angermann CE, Cleland JGF, et al. Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiol. 2020;5(4):401\u201310. https:\/\/doi.org\/10.1001\/jamacardio.2019.5108.","journal-title":"JAMA Cardiol."},{"issue":"9","key":"704_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. New Engl J Med. 2011;364(9):797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419.","journal-title":"New Engl J Med."},{"key":"704_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.04.002","author":"J Zheng","year":"2024","unstructured":"Zheng J, Ambrosy AP, Bhatt AS, et al. Contemporary decongestion strategies in patients hospitalized for heart failure: a national community-based cohort study. JACC Heart Fail. 2024. https:\/\/doi.org\/10.1016\/j.jchf.2024.04.002.","journal-title":"JACC Heart Fail."},{"issue":"11","key":"704_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cardfail.2018.08.007","volume":"24","author":"CE Hamo","year":"2018","unstructured":"Hamo CE, O\u2019Connor C, Metra M, Udelson JE, Gheorghiade M, Butler J. A critical appraisal of short-term end points in acute heart failure clinical trials. J Cardiac Fail. 2018;24(11):783\u201392. https:\/\/doi.org\/10.1016\/j.cardfail.2018.08.007.","journal-title":"J Cardiac Fail"},{"issue":"6","key":"704_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.5603\/CJ.a2019.0114","volume":"26","author":"P Balsam","year":"2019","unstructured":"Balsam P, Ozieranski K, Marchel M, et al. Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial. Cardiol J. 2019;26(6):661\u20138. https:\/\/doi.org\/10.5603\/CJ.a2019.0114.","journal-title":"Cardiol J"},{"issue":"3","key":"704_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jep.13261","volume":"26","author":"NA Sherif","year":"2020","unstructured":"Sherif NA, Morra ME, Thanh LV, et al. Torasemide versus furosemide in treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials. J Eval Clin Pract. 2020;26(3):842\u201351. https:\/\/doi.org\/10.1111\/jep.13261.","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"704_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","volume":"329","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Anstrom KJ, Eisenstein EL, et al. Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial. JAMA. 2023;329(3):214\u201323. https:\/\/doi.org\/10.1001\/jama.2022.23924.","journal-title":"JAMA"},{"key":"704_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113112","author":"AN Emara","year":"2022","unstructured":"Emara AN, Mansour NO, Elnaem MH, Wadie M, Dehele IS, Shams MEE. Efficacy of Nondiuretic pharmacotherapy for improving the treatment of congestion in patients with acute heart failure: a systematic review of randomised controlled trials. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11113112.","journal-title":"J Clin Med"},{"issue":"6","key":"704_CR33","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1002\/ehf2.14530","volume":"10","author":"R Nomura","year":"2023","unstructured":"Nomura R, Morishita T, Sato Y, et al. Effects of door-to-tolvaptan time on short-term clinical outcome in patients with acute heart failure. ESC Heart Fail. 2023;10(6):3573\u201381. https:\/\/doi.org\/10.1002\/ehf2.14530.","journal-title":"ESC Heart Fail."},{"key":"704_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijcard.2023.03.034","volume":"379","author":"H Takimura","year":"2023","unstructured":"Takimura H, Taniguchi R, Tsuzuki I, et al. Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure. Int J Cardiol. 2023;379:89\u201395. https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.034.","journal-title":"Int J Cardiol"},{"issue":"13","key":"704_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al. Acetazolamide in acute decompensated heart failure with volume overload. New Engl J Med. 2022;387(13):1185\u201395. https:\/\/doi.org\/10.1056\/NEJMoa2203094.","journal-title":"New Engl J Med."},{"issue":"6","key":"704_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cardfail.2014.03.006","volume":"20","author":"D Singh","year":"2014","unstructured":"Singh D, Shrestha K, Testani JM, et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Cardiac Fail. 2014;20(6):392\u20139. https:\/\/doi.org\/10.1016\/j.cardfail.2014.03.006.","journal-title":"J Cardiac Fail"},{"issue":"5","key":"704_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jchf.2019.01.007","volume":"7","author":"DZ Hodson","year":"2019","unstructured":"Hodson DZ, Griffin M, Mahoney D, et al. Natriuretic Response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial. JACC Heart Fail. 2019;7(5):383\u201391. https:\/\/doi.org\/10.1016\/j.jchf.2019.01.007.","journal-title":"JACC Heart Fail."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00704-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:14:48Z","timestamp":1745324088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00704-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,15]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00704-x","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,15]]},"assertion":[{"value":"4 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The is work was funded by School of Medicine, Indiana University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mary-Tiffany Oduah, Olubadewa A. Fatunde, Naba Farooqui, Lisa LeMond, Jacob Sama, Roopa Rao, and Onyedika J. Ilonze declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Mary-Tiffany Oduah conceptualized this study and was involved in study methodology and manuscript preparation (including writing, reviewing, and editing). Olubadewa A. Fatunde, Naba Farooqui, Lisa LeMond, Jacob Sama, and Roopa Rao were involved in study manuscript preparation (including reviewing and editing). Onyedika J. Ilonze conceptualized this study and was involved in study methodology and manuscript preparation (including writing, reviewing, and editing).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' Contributions"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}